Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

CHLORINE TEST REAGENT

Active
SPE2DS-27-T-0723Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Solicitation SPE2DS-27-T-0723 is a fixed-price procurement issued by the Department of Defense Medical Supply Chain for the supply of Chlorine Test Reagent (NSN 6550-01-460-7597). The requirement is for two packages, with each package containing 100 powder pillows for a 10 ML sample size using DPD Total Chlorine Reagent. Delivery is required within 5 days after receipt of order, with a specified delivery date of October 20, 2026, and the place of performance located in Pascagoula, Mississippi. The contract mandates strict quality and shelf-life requirements, specifying a non-extendable shelf life of 60 months, with no more than 8 months elapsed from the date of manufacture to the date of delivery. Packaging must be commercial and adhere to DLA Packaging Requirements for Procurement (RP001), with medical acquisitions specifically requiring marking according to Medical Marking Standard No. 1. All labels must include the contract or lot number and the manufacture, expiration, or retest date. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. Offerors must be registered in the System for Award Management (SAM) and comply with the Buy American Act and DFARS safeguarding of covered defense information. Inspection and acceptance will occur at the destination.

General Info

DoD fixed-price contract for supplying Chlorine Test Reagents to Pascagoula, Mississippi.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

PO BOX 7003, PASCAGOULA, MS, 39567, USA

Set-Aside

NONE

Documents

1

RFQ SPE2DS-27-T-0723

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF
Contacts1 person available
OfficeUSA

Full Description

Show more
CHLORINE TEST REAGENT
CHLORINE TEST REAGENT
FEATURES DPD TOTAL CHLORINE REAGENT; 10 ML SAMPLE SIZE, 100 POWDER
PILLOWS
UNIT OF ISSUE: PG (100 X 10 ML EACH PER PACKAGE)
..
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
..
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
..
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
..
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
..
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
.. RS023: Shelf-life requirement RS001 for a TYPE I (CODE S) item with a shelf life of 60 months (non-extendable) applies to this item.
SPE2DS-27-T-0723
SECTION B
SHALL HAVE A SHELF LIFE OF 60 MONTHS.
NOT MORE THAN 8 MONTHS SHALL HAVE ELAPSED FROM
DATE OF MANUFACTURE TO DATE OF DELIVERY TO THE
GOVERNMENT.
.
SHELF LIFE MARKINGS SHALL BE IN ACCORDANCE WITH
THE LATEST REVISION OF MMS1C.
. ALL LABELS SHALL INCLUDE:
DATE OF MANUFACTURE, EXPIRATION, OR RETEST DATE
CONTRACT NUMBER/LOT NUMBER.
..
ADEQUATE DATA FOR THE NSN/Part Number: 6550-01-460-7597 Quantity: 2 PG Purchase Request: 7018753520QTY: 2 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America
Solicitation # 36E79726R0041
The Department of Veterans Affairs intends to award a firm-fixed requirements-type contract for Sodium Bicarbonate 84mg/mL Injection 50mL vials, with an estimated annual usage of 65,587 bottles. This procurement is restricted to suppliers with products manufactured in the United States in accordance with FAR 6.103-3 and will be issued in a commercial item format per FAR Part 12. The contract will support multiple agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed through the VA and DOD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a base period of one year, with four pre-priced one-year option periods. Under NAICS code 325412, the solicitation requires offerors to provide a unique NDC number and the exact drug name as it appears on the label. Strict labeling standards apply: the contractor's unique NDC label must be the only label on the product, and labels cannot be affixed over existing ones; however, they must allow VA labels to adhere securely on top. While glass bottles are acceptable, all packaging must be compatible with automated dispensing units such as Opti-fill and Baxter ATC Canisters. The solicitation is expected to be issued on October 21, 2026, with a tentative closing date of November 18, 2026, and all communications and submissions must be handled electronically via SAM.gov.
Nac Pharmaceuticals (36E797)

POSTED

2 days ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
Federal
6505--Imatinib Tablets
Solicitation # 36E79726R0036
The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.
Nac Pharmaceuticals (36E797)

POSTED

2 days ago

DEADLINE

in 12 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS